Next Article in Journal
Genome-Wide Association Study for Multiple Biotic Stress Resistance in Synthetic Hexaploid Wheat
Next Article in Special Issue
Anti-Aging Potential of Substance P-Based Hydrogel for Human Skin Longevity
Previous Article in Journal
Involvement of Lhcb6 and Lhcb5 in Photosynthesis Regulation in Physcomitrella patens Response to Abiotic Stress
Previous Article in Special Issue
Caffeic Acid Phenethyl Ester Inhibits UV-Induced MMP-1 Expression by Targeting Histone Acetyltransferases in Human Skin
Open AccessReview

Melanocyte Activation Mechanisms and Rational Therapeutic Treatments of Solar Lentigos

Center for Bioscience Research & Education, Utsunomiya University, 350 Mine Utsunomiya, Tochigi 321-8505, Japan
Int. J. Mol. Sci. 2019, 20(15), 3666; https://doi.org/10.3390/ijms20153666
Received: 12 June 2019 / Revised: 11 July 2019 / Accepted: 24 July 2019 / Published: 26 July 2019
(This article belongs to the Special Issue Molecular Mechanisms of Skin Aging)
To characterize the pathobiology of solar lentigos (SLs), analyses by semiquantitative RT-PCR, Western blotting, and immunohistochemistry revealed the upregulated expression of endothelin (EDN)-1/endothelin B receptors (EDNBRs), stem cell factor (SCF)/c-KIT, and tumor necrosis factor (TNF)α in the lesional epidermis, which contrasted with the downregulated expression of interleukin (IL) 1α. These findings strongly support the hypothesis that previous repeated UVB exposure triggers keratinocytes to continuously produce TNFα. TNFα then stimulates the secretion of EDNs and the production of SCF in an autocrine fashion, leading to the continuous melanogenic activation of neighboring melanocytes, which causes SLs. A clinical study of 36 patients with SLs for six months treated with an M. Chamomilla extract with a potent ability to abrogate the EDN1-induced increase in DNA synthesis and melanization of human melanocytes in culture revealed a significant improvement in pigment scores and color differences expressed as L values. Another clinical study using a tyrosinase inhibitor L-ascorbate-2-phosphate 3 Na (ASP) demonstrated that L values of test lotion (6% APS)-treated skin significantly increased in SLs and in non-lesional skin with a significantly higher ΔL value in SLs when compared with non-lesional skin. The sum of these findings strongly suggests that combined topical treatment with EDN signaling blockers and tyrosinase inhibitors is a desirable therapeutic choice for SLs. View Full-Text
Keywords: solar lentigo; endothelin; stem cell factor; keratinocyte growth factor; interleukin-1; tumor necrosis factor α; intracellular signaling; calcium mobilization; signaling blocker; M. chamomilla; ascorbate-phosphate Na; whitening agent; tyrosinase inhibitor solar lentigo; endothelin; stem cell factor; keratinocyte growth factor; interleukin-1; tumor necrosis factor α; intracellular signaling; calcium mobilization; signaling blocker; M. chamomilla; ascorbate-phosphate Na; whitening agent; tyrosinase inhibitor
Show Figures

Figure 1

MDPI and ACS Style

Imokawa, G. Melanocyte Activation Mechanisms and Rational Therapeutic Treatments of Solar Lentigos. Int. J. Mol. Sci. 2019, 20, 3666.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop